15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
33
Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In Vivo.
Shanghai Institute of Materia Medica
6
Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
Smith, Gambrell & Russell
37
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.
Shanghai Institute of Materia Medica
23
Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.
Yancheng Teachers University
2
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead
Merck Healthcare
4
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
Lille Neuroscience and Cognition Research Center
37
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.
Max Planck Institute of Molecular Physiology
2
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
University of Bristol
6
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.
Zhengzhou University
154
COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1 R)
Norwegian University of Science and Technology
9
UNIT DOSAGE COMPOSITION OF AKT INHIBITOR
Nanjing Chia Tai Tianqing Pharmaceutical